Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Assessing and Improving Balance Using Platform Perturbations

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2010 by Kessler Foundation.
Recruitment status was:  Active, not recruiting
Sponsor:
Information provided by:
Kessler Foundation
ClinicalTrials.gov Identifier:
NCT01207362
First received: September 21, 2010
Last updated: NA
Last verified: September 2010
History: No changes posted
  Purpose
The purpose of this study is to compare current standing balance assessment methods to a new method that measures weight shift during small movements of a sliding platform. It will also be used to determine if balance improves with repeated exposure as part of a 4-week training program.

Condition Phase
Balance
Phase 0

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Cross-Sectional
Official Title: Assessing and Improving Balance Using Platform Perturbations

Further study details as provided by Kessler Foundation:

Primary Outcome Measures:
  • Improvement in static sway [ Time Frame: 20 days ] [ Designated as safety issue: No ]

Estimated Enrollment: 4
Study Start Date: August 2009
Estimated Study Completion Date: December 2010
Estimated Primary Completion Date: August 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts
Young adult
Older adult

  Eligibility

Ages Eligible for Study:   20 Years to 65 Years   (Adult)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Healthy adults
Criteria

Inclusion Criteria:

  • Healthy no balance deficits age 20-35 or 50-65

Exclusion Criteria:

  • moderate to severe arthritis
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01207362

Locations
United States, New Jersey
Kessler Foundation Research Center
W. Orange, New Jersey, United States, 07052
Sponsors and Collaborators
Kessler Foundation
  More Information

Responsible Party: Kevin Terry, PI, Kessler Foundation Research Center
ClinicalTrials.gov Identifier: NCT01207362     History of Changes
Other Study ID Numbers: R-648-09 
Study First Received: September 21, 2010
Last Updated: September 21, 2010
Health Authority: United States: Institutional Review Board

ClinicalTrials.gov processed this record on December 02, 2016